Plasma total homocysteine levels and other biochemical parameters in Algerian patients with deep vein thrombosis

被引:0
作者
Amrane, Mounira [2 ]
Begag, Samia [3 ]
Houcher, Zahira [3 ]
Houcher, Bakhouche [1 ]
Touabti, Abderrezak [2 ]
Nasri, Ramdane [4 ]
Boussouf, Kheira [5 ]
Khattabi, Soumia [6 ]
机构
[1] Univ Setif 1, Fac Life & Nat Sci, Setif 19000, Algeria
[2] Univ Setif 1, Med Biochem Lab, Fac Med, Setif 19000, Algeria
[3] Univ Setif 1, Fac Life & Nat Sci, Setif 19000, Algeria
[4] Univ Constantine, Inst Chem, Fac Sci, Constantine 2500, Algeria
[5] Univ Setif 1, Fac Med, Dept Cardiol, Setif 19000, Algeria
[6] Univ Setif 1, Fac Med, Dept Internal Med, Setif 19000, Algeria
关键词
Algerian; deep venous thrombosis; homocysteine; lipid profile; FACTOR-V-LEIDEN; RISK-FACTOR; VENOUS THROMBOSIS; CARDIOVASCULAR-DISEASE; VASCULAR-DISEASE; METHYLENETETRAHYDROFOLATE REDUCTASE; FOLIC-ACID; HYPERHOMOCYSTEINEMIA; PREVALENCE; C677T;
D O I
10.1515/pterid-2014-0009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We studied total plasma homocysteine levels (tHcy) in Algerian patients with a deep venous thrombosis (DVT). We measured tHcy levels in a total of 99 subjects enrolled in this study, including 40 patients with DVT and 59 healthy controls. The mean tHcy level in the patients was 12.62 +/- 8.7 mu mol/L and that in the controls was 10.2 +/- 2.1 mu mol/L. In a univariate regression model, tHcy concentrations were inversely correlated with triglycerides (TG) (r = -0.358; p = 0.023) and total cholesterol (TC) (r = -0.454; p = 0.003) concentrations. Logistic regression analysis showed that tHcy after adjustment was significantly associated with the following factors: TC (p = 0.003) and TG (p = 0.023). The analysis in DVT patients showed that variables independently associated with tHcy were TC [ odds ratio (OR) 2.1, 95% confidence interval (CI) 1.7-2.6], low-density lipoprotein cholesterol (OR 2.0, 95% CI 1.6-2.5), creatinine (OR 2.2, 95% CI 1.7-2.6), and smoking (OR 2.1, 95% CI 1.7-2.5). In conclusion, these results indicate that tHcy levels and other biochemical parameters are important determinant factors for DVT diseases in Algerian patients.
引用
收藏
页码:69 / 74
页数:6
相关论文
共 50 条
[1]   PLASMA HOMOCYSTEINE LEVELS IN PATIENTS WITH DEEP VENOUS THROMBOSIS [J].
AMUNDSEN, T ;
UELAND, PM ;
WAAGE, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (09) :1321-1323
[2]  
[Anonymous], ATHEROSCLEROTIC CARD
[3]   HYPERHOMOCYSTEINEMIA IN PATIENTS OPERATED FOR LOWER-EXTREMITY ISCHEMIA BELOW THE AGE OF 50 - EFFECT OF SMOKING AND EXTENT OF DISEASE [J].
BERGMARK, C ;
MANSOOR, MA ;
SWEDENBORG, J ;
DEFAIRE, U ;
SVARDAL, AM ;
UELAND, PM .
EUROPEAN JOURNAL OF VASCULAR SURGERY, 1993, 7 (04) :391-396
[4]   ELEVATED TOTAL PLASMA HOMOCYSTEINE, A RISK FACTOR FOR THROMBOSIS - RELATION TO COAGULATION AND FIBRINOLYTIC PARAMETERS [J].
BIENVENU, T ;
ANKRI, A ;
CHADEFAUX, B ;
MONTALESCOT, G ;
KAMOUN, P .
THROMBOSIS RESEARCH, 1993, 70 (02) :123-129
[5]   Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes [J].
Bostom, AG ;
Lathrop, L .
KIDNEY INTERNATIONAL, 1997, 52 (01) :10-20
[6]   The Prevalence of Methylenetetrahydrofolate Reductase 677 C-T, Factor V 1691 G-A, and Prothrombin 20210 G-A Mutations in Healthy Populations in Setif, Algeria [J].
Bourouba, Romyla ;
Houcher, Bakhouche ;
Djabi, Farida ;
Egin, Yonca ;
Akar, Nejat .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2009, 15 (05) :529-534
[7]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[8]  
BRATTSTROM L, 1991, HAEMOSTASIS, V21, P51
[9]   HOMOCYSTEINE AND CYSTEINE - DETERMINANTS OF PLASMA-LEVELS IN MIDDLE-AGED AND ELDERLY SUBJECTS [J].
BRATTSTROM, L ;
LINDGREN, A ;
ISRAELSSON, B ;
ANDERSSON, A ;
HULTBERG, B .
JOURNAL OF INTERNAL MEDICINE, 1994, 236 (06) :633-641
[10]  
Brezovska-Kavrakova Julijana, 2013, Mater Sociomed, V25, P170, DOI 10.5455/msm.2013.25.170-174